CN104736161B - 预防和治疗非典型性骨质疏松的制剂和方法 - Google Patents

预防和治疗非典型性骨质疏松的制剂和方法 Download PDF

Info

Publication number
CN104736161B
CN104736161B CN201280074021.7A CN201280074021A CN104736161B CN 104736161 B CN104736161 B CN 104736161B CN 201280074021 A CN201280074021 A CN 201280074021A CN 104736161 B CN104736161 B CN 104736161B
Authority
CN
China
Prior art keywords
osteoporosis
bone
vitamin
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280074021.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN104736161A (zh
Inventor
V·I·斯特克鲁夫
O·霍内斯
E·N·克鲁季科夫
K·G·叶利斯特拉托夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parafarm OOO
Original Assignee
Parafarm OOO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parafarm OOO filed Critical Parafarm OOO
Publication of CN104736161A publication Critical patent/CN104736161A/zh
Application granted granted Critical
Publication of CN104736161B publication Critical patent/CN104736161B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
CN201280074021.7A 2012-04-19 2012-08-21 预防和治疗非典型性骨质疏松的制剂和方法 Active CN104736161B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012115654 2012-04-19
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (2)

Publication Number Publication Date
CN104736161A CN104736161A (zh) 2015-06-24
CN104736161B true CN104736161B (zh) 2021-07-06

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280074021.7A Active CN104736161B (zh) 2012-04-19 2012-08-21 预防和治疗非典型性骨质疏松的制剂和方法

Country Status (17)

Country Link
US (1) US9827273B2 (enExample)
EP (1) EP2845598B1 (enExample)
JP (1) JP6286417B2 (enExample)
CN (1) CN104736161B (enExample)
AU (1) AU2012377476B2 (enExample)
BR (1) BR112014025990B1 (enExample)
CA (1) CA2870823C (enExample)
DK (1) DK2845598T3 (enExample)
EA (1) EA026533B1 (enExample)
ES (1) ES2616035T3 (enExample)
IL (1) IL235169B (enExample)
IN (1) IN2014DN09780A (enExample)
LT (1) LT2845598T (enExample)
PL (1) PL2845598T3 (enExample)
RU (1) RU2497533C1 (enExample)
UA (1) UA111536C2 (enExample)
WO (1) WO2013157982A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1168273A (zh) * 1997-07-24 1997-12-24 薛大权 蜂蛹钙制剂
CN101951919A (zh) * 2008-02-13 2011-01-19 帝斯曼知识产权资产管理有限公司 维生素d3和25-羟基-维生素d3用于治疗骨质疏松症和改善骨矿物质密度的组合用途
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526845A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1168273A (zh) * 1997-07-24 1997-12-24 薛大权 蜂蛹钙制剂
CN101951919A (zh) * 2008-02-13 2011-01-19 帝斯曼知识产权资产管理有限公司 维生素d3和25-羟基-维生素d3用于治疗骨质疏松症和改善骨矿物质密度的组合用途
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
妇女绝经期后骨质疏松的药物治疗现状;路通等;《辽宁中医药大学学报》;20080105;第10卷(第01期);51-52 *

Also Published As

Publication number Publication date
RU2497533C1 (ru) 2013-11-10
UA111536C2 (uk) 2016-05-10
BR112014025990A2 (pt) 2017-06-27
AU2012377476B2 (en) 2017-10-05
AU2012377476A8 (en) 2014-12-18
LT2845598T (lt) 2017-02-27
JP2015516974A (ja) 2015-06-18
PL2845598T3 (pl) 2017-07-31
ES2616035T3 (es) 2017-06-09
DK2845598T3 (en) 2017-04-10
US9827273B2 (en) 2017-11-28
AU2012377476A1 (en) 2014-12-11
EA026533B1 (ru) 2017-04-28
CA2870823A1 (en) 2013-10-24
EA201401155A1 (ru) 2015-05-29
IL235169A0 (en) 2014-12-31
CN104736161A (zh) 2015-06-24
US20150224150A1 (en) 2015-08-13
IL235169B (en) 2019-10-31
IN2014DN09780A (enExample) 2015-07-31
WO2013157982A1 (ru) 2013-10-24
EP2845598B1 (en) 2017-01-04
JP6286417B2 (ja) 2018-02-28
BR112014025990B1 (pt) 2021-02-17
CA2870823C (en) 2017-10-03
EP2845598A1 (en) 2015-03-11
EP2845598A4 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
CN104736161B (zh) 预防和治疗非典型性骨质疏松的制剂和方法
JP2015516974A5 (ja) 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤
JP6286418B2 (ja) 骨粗鬆症もしくは骨折の予防または治療剤
US20180015122A1 (en) Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
EP1980255A1 (en) Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause
JP6279529B2 (ja) 虚弱を治療する方法
Goel et al. Role of L arginine in treatment of osteoporosis
JP2010523563A (ja) 骨折および骨欠損の処置のためのハーブ製剤
RU2804251C1 (ru) Способ увеличения минеральной плотности костной ткани у пациентов с остеопорозом, полинейропатией, при сахарном диабете 2 типа
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
Ponnapakkam et al. A fusion protein of parathyroid hormone (PTH) and a collagen binding domain shows superior efficacy and longer duration of action compared to PTH (1–34) as an anabolic bone agent in normal female mice
WO2010126094A1 (ja) エルデカルシトールを含有する重症骨粗鬆症患者での非外傷性椎体骨折抑制剤
Shrestha The effect of alfacalcidol and plain vitamin d on osteoporosis: A randomised controlled trial
CN118662581A (zh) 仙灵骨葆药物组合物在制备治疗乳腺癌内分泌治疗相关骨质疏松症的药物中的用途
Oryan et al. Journal of Sports Medicine and Doping Studies
Jancin Teriparatide Speeds Healing of Fractures
Gifre et al. Denosumab Increases Sublesional Bone Mass In Osteoporotic Patients With Recent Spinal Cord Injury
Ofek et al. Skeletal anabolic activity of cannabinoid receptor agonists
Taha et al. Calcitonin Versus Disodium Clodronate therapy in treatment of postmenopausal osteoporosis in Tikrit city.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant